Because the effectiveness of the current oral options ... review discusses various topical antibiotic treatment options for uncomplicated skin infections, including over-the-counter and prescribed ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

USA: The management of fracture-related infections (FRIs) often involves prolonged antibiotic therapy, with intravenous (IV) ...

Opens in a new tab or window According to the company, the product is the first and only fixed-dose, intravenous, monobactam/beta-lactamase inhibitor combination antibiotic to receive FDA approval.

A dentist may prescribe antibiotics to reduce the infection and stop it from spreading ... include symptoms such as a painful tongue and mouth, swelling of the face, cheeks, or neck, and ...

Antibiotics can wipe out good bacteria in your gut and cause uncomfortable side effects. Dietitians share what to eat to feel better.

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on ...

With flu season in town again, people are looking for effective treatments. But not all of these treatments are safe.

A variety of viruses are circulating across Northeast Mississippi this winter, and their treatment differs from bacterial infections. Dr. John Cantrell, an urgent care doctor at the Fulton Medical ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.